Gemcitabine News and Research

RSS
Gemcitabine is the active ingredient in a drug that is used to treat pancreatic cancer that is advanced or has spread. It is also used together with other drugs to treat breast cancer that has spread, advanced ovarian cancer, and non-small cell lung cancer that is advanced or has spread. It is also being studied in the treatment of other types of cancer. Gemcitabine blocks the cell from making DNA and may kill cancer cells. It is a type of antimetabolite
Chemo-immunotherapy combination shows promise against pancreatic cancer

Chemo-immunotherapy combination shows promise against pancreatic cancer

Novel drug combination can boost chemoimmunotherapy response in bladder cancer patients

Novel drug combination can boost chemoimmunotherapy response in bladder cancer patients

New therapy makes immunologically 'cold' tumors hot enough for immune attack

New therapy makes immunologically 'cold' tumors hot enough for immune attack

Study: Ketogenic diet helps kill pancreatic cancer cells when combined with a triple-drug therapy

Study: Ketogenic diet helps kill pancreatic cancer cells when combined with a triple-drug therapy

Biomarker could predict pathologic response to chemotherapy among bladder cancer patients

Biomarker could predict pathologic response to chemotherapy among bladder cancer patients

Ketogenic diet could enhance the efficacy of chemotherapy for pancreatic cancer, study shows

Ketogenic diet could enhance the efficacy of chemotherapy for pancreatic cancer, study shows

Death rates from ovarian cancer are predicted to fall by 2022 in EU countries

Death rates from ovarian cancer are predicted to fall by 2022 in EU countries

A class of FDA-approved drugs can effectively stop aggressive uterine cancer

A class of FDA-approved drugs can effectively stop aggressive uterine cancer

Researchers analyze live bacteria from cystic lesions that are precursors to pancreatic cancer

Researchers analyze live bacteria from cystic lesions that are precursors to pancreatic cancer

Adding berzosertib to standard treatment for metastatic urothelial cancer does not extend patient survival

Adding berzosertib to standard treatment for metastatic urothelial cancer does not extend patient survival

Stimulating immune cells to form special structures can potentiate pancreatic cancer chemotherapy

Stimulating immune cells to form special structures can potentiate pancreatic cancer chemotherapy

SWOG researchers to present practice-changing research at virtual ASCO 2021

SWOG researchers to present practice-changing research at virtual ASCO 2021

An ion pump tested as a possible method to treat malignant brain tumors

An ion pump tested as a possible method to treat malignant brain tumors

The Dream Team opens clinical trial to find better treatment options for pancreatic cancer

The Dream Team opens clinical trial to find better treatment options for pancreatic cancer

Novel biomarker may help identify which pancreatic cancer patients respond to CD40 agonists

Novel biomarker may help identify which pancreatic cancer patients respond to CD40 agonists

Combining PD-1 and VEGF inhibitors with chemotherapy can help control cholangiocarcinoma

Combining PD-1 and VEGF inhibitors with chemotherapy can help control cholangiocarcinoma

Phase III study of (m)RNA expression did not confer significant advantage for stage II-III lung cancer

Phase III study of (m)RNA expression did not confer significant advantage for stage II-III lung cancer

Researchers develop an easier way to deliver pancreatic cancer drugs

Researchers develop an easier way to deliver pancreatic cancer drugs

Researchers discover a new approach to inhibit intrahepatic cholangiocarcinoma

Researchers discover a new approach to inhibit intrahepatic cholangiocarcinoma

Researchers identify new way to disrupt process that promotes the growth of pancreatic cancers

Researchers identify new way to disrupt process that promotes the growth of pancreatic cancers